4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-020920
Chief Legal Officer acquired 9,018 shares (other)
From the SEC's structured data for this filing
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-020920
Chief Legal Officer acquired 9,018 shares (other)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…